CHMP2B and frontotemporal dementia: For instance, miR-124-3p was found to be decreased in the frontal lobe of C9ORF72 and MAPT carriers in our study, which is consistent with its association with synaptic dysfunction mediated by CHMP2B mutations, another risk gene for FTD [42].